FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): Are they reasonable?

Garry Graham, Richard Day, Andis Graudins, Anthoulla Mohamudally

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)

Abstract

Hepatotoxicity from paracetamol is of great concern because of the considerable number of patients who develop severe toxicity from this drug. A group of senior medical practitioners, academics and scientists were brought together on June 29 and 30, 2009 by the Food and Drug Administration of USA (FDA) with the aim of providing advice on how to limit the number of cases of hepatotoxicity due to paracetamol in USA.
Original languageEnglish
Pages (from-to)47 - 55
Number of pages9
JournalInflammopharmacology
Volume18
Issue number57
DOIs
Publication statusPublished - 2010

Cite this